![Jones Woody Bryan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jones Woody Bryan
Directeur Général chez
Revolo Biotherapeutics Ltd.
Profil
Jones Woody Bryan currently works at Revolo Biotherapeutics Ltd., as President, Chief Executive Officer & Director from 2024, Afecta Pharmaceuticals, Inc., as Director, and Licensing Executives Society, as Member.
Dr. Bryan also formerly worked at Arthur M Spiro Institute For Entrepreneurial Leadrship, as Chairman, AAI Corp., as Director-Business Development, Sucampo Pharmaceuticals LLC, as Senior Vice President-Business Development, Supernus Pharmaceuticals, Inc., as Vice President-Business Development from 2010 to 2015, Shire Laboratories, Inc., as Vice President-Business Development from 2000 to 2007, Lupin Pharmaceuticals, Inc., as Senior Vice President-Business Development, and UroGen Pharma Ltd., as Senior Vice President-Business Development from 2018 to 2020.
Dr. Bryan received his doctorate degree from Medical University of South Carolina and undergraduate degree from Clemson University.
Postes actifs de Jones Woody Bryan
| Sociétés | Poste | Début |
|---|---|---|
Licensing Executives Society
 Licensing Executives Society Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization that provides world leading events, useful resources and publications for deal-making, education and best practices | Corporate Officer/Principal | 29/12/2010 |
Afecta Pharmaceuticals, Inc.
 Afecta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afecta Pharmaceuticals, Inc. is an early clinical-stage biotech company specializing in the discovery and development of precision medicines for chronic disorders and cancers, with a focus on conditions prevalent in women and children. The company is based in Irvine, CA. The company’s pipeline targets neurology, ophthalmology, oncology, and dermatology, addressing unmet medical needs such as neurodevelopmental and neurodegenerative diseases, chronic immune-mediated ocular inflammation, retinal degenerative diseases, and various cancers including glioblastoma and malignant melanoma. Afecta employs proprietary technologies, including a computational platform for drug discovery and design and nanomaterial-based drug delivery systems, to create multi-targeted therapeutics that modulate multiple disease pathways simultaneously. The company's lead neurological drug treats disruptive behaviors in neurodevelopmental disorders like autism and ADHD, while other candidates target Parkinson’s disease, ocular inflammation, diabetic retinopathy, and cancer. | Directeur/Membre du Conseil | - |
Revolo Biotherapeutics Ltd.
 Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops immunologic and inflammatory medications | Directeur Général | 22/02/2024 |
Anciens postes connus de Jones Woody Bryan
| Sociétés | Poste | Fin |
|---|---|---|
| UROGEN PHARMA LTD. | Corporate Officer/Principal | 01/07/2020 |
| SUPERNUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 09/04/2015 |
Shire Laboratories, Inc.
 Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technologies | Corporate Officer/Principal | 12/10/2007 |
Arthur M Spiro Institute For Entrepreneurial Leadrship
 Arthur M Spiro Institute For Entrepreneurial Leadrship Other Consumer ServicesConsumer Services Functions as a College/University | Président | - |
Lupin Pharmaceuticals, Inc.
 Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes generic formulations, biotechnology products & APIs | Corporate Officer/Principal | - |
Formation de Jones Woody Bryan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
AAI Corp.
 AAI Corp. Information Technology ServicesTechnology Services Develops unmanned aircraft systems for training and simulation activities | Technology Services |
Medical University of South Carolina
 Medical University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clemson University
 Clemson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
 Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technologies | Commercial Services |
Licensing Executives Society
Licensing Executives Society Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization that provides world leading events, useful resources and publications for deal-making, education and best practices | Commercial Services |
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes generic formulations, biotechnology products & APIs | Health Technology |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
Afecta Pharmaceuticals, Inc.
Afecta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afecta Pharmaceuticals, Inc. is an early clinical-stage biotech company specializing in the discovery and development of precision medicines for chronic disorders and cancers, with a focus on conditions prevalent in women and children. The company is based in Irvine, CA. The company’s pipeline targets neurology, ophthalmology, oncology, and dermatology, addressing unmet medical needs such as neurodevelopmental and neurodegenerative diseases, chronic immune-mediated ocular inflammation, retinal degenerative diseases, and various cancers including glioblastoma and malignant melanoma. Afecta employs proprietary technologies, including a computational platform for drug discovery and design and nanomaterial-based drug delivery systems, to create multi-targeted therapeutics that modulate multiple disease pathways simultaneously. The company's lead neurological drug treats disruptive behaviors in neurodevelopmental disorders like autism and ADHD, while other candidates target Parkinson’s disease, ocular inflammation, diabetic retinopathy, and cancer. | Health Technology |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops immunologic and inflammatory medications | Health Technology |
Arthur M Spiro Institute For Entrepreneurial Leadrship
Arthur M Spiro Institute For Entrepreneurial Leadrship Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
